MEDICINES PRICE RATIO OF PUBLIC PROCUREMENT PRICE OF GENERIC MEDICINES IN INDONESIA Anggriani, Y.1, Mohamed Izham, M.I.2, Suryawati, S.3, Budiarto, M.4, Shafie, A.A.5 1Faculty of Pharmacy Pancasila University , Jakarta , Indonesia 2Department of Pharmacy Practice, College of Pharmacy , Qatar University, Doha , Qatar 3Center for Clinical Pharmacology and Medicine Policy Studies, Gadjah Mada University , Yogyakarta , Indonesia 4 National Institute Of Health Research and Development, Ministry of Health, Jakarta , Indonesia 5School Of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia Medicine is an important part in health care systems. Approximately 20-60% of health costs in developing countries is used for medicines (WHO, 2004). Medicine is one of the factors that cause inefficiencies in the health care service (WHO, 2010). Public access to medicines should be a concern for health providers either both government or private (Donald, 2001). The objective of the study is to evaluate medicines price ratios (MPRs) of the generic medicines of procurement prices in the public sector. The study design was a cross-sectional survey of 6 District Health Offices from 3 provinces, 9 public hospitals from 4 provinces, and 7 health centers in Jakarta Provinces. Fifty medicines were surveyed: 14 global, 15 regional and 21 supplementary medicines. Procurement prices were surveyed in 2010. Only medicines which available at more than 4 facilities were analyzed. Outcome measures of this study is MPRs of generic medicines procurement price in public sectors. MPRs is the median local cost (in rupiah) divided by the median international reference price/IRP 2009 (converted to rupiah using the exchange rate on the first day of data collection). The MPRs results describe how much greater or smaller the local medicine price is to the international reference price. MPRs 3-4 means that the price in Indonesia is 3-4 times the IRP. WHO and HAI consider an MPR ≤ 1 to indicate that procurement for the public sector is efficient. Larger price ratios are considered excessive (HAI & WHO, 2004). 36 generic medicines price were evaluated; 14 medicines were not evaluated due to unavailable at more than 4 facilities. The results of MPRs of the public procurement price of generic medicine were: MPRs <1 (11 items); MPRs >1-2 (20 items); MPRs > 2-3 (1 item); MPRs > 3-4 (3 items); MPRs > 5 (1 item). Based on the WHO and HAI standards, the MPRs of the procurement price of medicines surveyed in Indonesia is still excessive and non-efficient. Key Words: Generic medicines, MPRs, procurement price, public sector. The 24th Federation Of Asian Pharmaceutical Association (FAPA) Congress 2012 Bali Nusa Dua Convention Center - Bali, Indonesia, September 13 - 16, 2012 .